Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06348134 |
Title | Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery |
Recruitment | Not yet recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Chicago |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |